Adam FeuersteinOvjeren akaunt

@adamfeuerstein

Senior Writer at . I am the Night King of biotech. Data Are. Dogs rule. Said one analyst: The likes of Adam Feuerstein attack viciously.

Boston, MA
statnews.com
Vrijeme pridruživanja: siječanj 2010.
4.130 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @adamfeuerstein

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @adamfeuerstein

  1. Prikvačeni tweet
    13. lis 2018.

    A thread about selflessness, sacrifice and gratitude: My wife was her mom’s primary caregiver for the past 8 years, right up to her mom’s death this week. Her mom lived with us, and my wife cared for her full time through declining health.

    84 proslijeđena tweeta 815 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  2. prije 41 minutu

    This additional Nestle investment in is a smart, strategic move. Non-dilutive financing. I had forgotten Nestle was an Aimmune owner. While this deal tamps down immediate buyout speculation, you do wonder if that might happen long term.

    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  3. prije 3 sata

    to spin off new $6.5 billion firm focused on women’s health, older drugs speaks with Merck CEO Ken Frazier.

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  4. prije 3 sata

    Antibody drug, not vaccine. Doh! Brain was still foggy this morning. I was up late last night way past my bedtime binging on episodes of Fleabag. Wow, incredible show.

    gave access to the Tarrytown labs where the early work on a vaccine is being done. Great story.
    1 reply 1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    prije 3 sata

    .⁦⁩ and I wrote about the conversational AIs that are trying to screen for

    5 proslijeđenih tweetova 8 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    prije 4 sata

    Great read! Faster to get to a workable antibody than a vaccine. Why I like chances more than vaccine manufacturers

    The novel arrived at Regeneron Pharmaceuticals’ sprawling campus like any other parcel: inside a cardboard box.
    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  7. prije 5 sati

    gave access to the Tarrytown labs where the early work on a vaccine is being done. Great story.

    The novel arrived at Regeneron Pharmaceuticals’ sprawling campus like any other parcel: inside a cardboard box.
    7 proslijeđenih tweetova 10 korisnika označava da im se sviđa
    Poništi
  8. prije 18 sati

    on call: No knowledge of additional responses to remdesivir. Waiting for clinical data. On manufacturing capacity: “We are investing heavily to be prepared as best we can.”

    1 reply 6 proslijeđenih tweetova 24 korisnika označavaju da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    4. velj

    Don't think this is sell the news; more likely that potential rough launch is getting priced in. The call was quite revealing

    If you missed our (timely!) Expert Advantage call yesterday, the Transcript, Recording, & Survey of 30 Allergists are all available for your review. Access speaking with Dr. Wood (& the views of 30 allergists) here:
    1 reply 2 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  10. 4. velj

    Happy F—king Birthday to ! He’s old.

    6 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    4. velj

    The very talented nailed it with this illustration for 's delightful story this morning : If biotech had a Mount Rushmore, whose heads would you chisel in the granite? via

    1 reply 6 proslijeđenih tweetova 6 korisnika označava da im se sviđa
    Poništi
  12. 4. velj

    True. (Sent by a friend, origin unknown, but 👏🏻)

    5 replies 43 proslijeđena tweeta 158 korisnika označava da im se sviđa
    Poništi
  13. 4. velj

    If biotech had a Mount Rushmore, whose heads would you chisel in the granite? Biotech CEOs only. I have some thoughts here, but want to hear your nominees. Leave in comments. FREE column.

    29 replies 11 proslijeđenih tweetova 28 korisnika označava da im se sviđa
    Poništi
  14. 4. velj

    Experts envision two scenarios if the new isn’t contained via

    48 proslijeđenih tweetova 85 korisnika označava da im se sviđa
    Poništi
  15. 4. velj

    The VC firm Andreessen Horowitz once pledged to never invest in health care. Now it’s launching its third life sciences fund via

    1 reply 12 korisnika označava da im se sviđa
    Poništi
  16. 3. velj

    Quick retraction of a faulty paper was a good moment for science via

    6 replies 11 proslijeđenih tweetova 28 korisnika označava da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    3. velj

    .' coverage can be found here:

    7 replies 38 proslijeđenih tweetova 60 korisnika označava da im se sviđa
    Poništi
  18. 3. velj

    Leerink spox got back to me with an explanation on the transfer of research coverage:

    1 reply 1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Poništi
  19. 3. velj

    To fight spread, the U.S. may expand ‘social distancing’ measures. But it comes at a cost. via

    6 proslijeđenih tweetova 4 korisnika označavaju da im se sviđa
    Poništi
  20. 3. velj

    More evidence that FDA’s Breakthrough Therapy Designation has lost all meaning or significance: granted BTD for apabetalone AFTER the failure of a phase 3 clinical trial.

    5 replies 4 proslijeđena tweeta 31 korisnik označava da mu se sviđa
    Poništi
  21. 3. velj

    Chan Zuckerberg Initiative to fund 30 patient groups, aiming to build a model for tackling rare diseases via

    3 proslijeđena tweeta 21 korisnik označava da mu se sviđa
    Poništi

@adamfeuerstein još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·